The MHRA is working closely with the Department for Health and Social Care and other healthcare partners on COVID-19.
They are prioritising work including:
- Supporting and authorising the development of vaccines
- Clinical trials of new medicines
- Managing the supply of medicines and healthcare products
They also provide information to patients, manufacturers and healthcare professionals through established information channels and alert systems. This updated information is vital to industry partners, clinicians and researchers working to ameliorate the diagnosis, risk, care and aftercare of COVID-19 within our population.
The National Institute for Biological Standards and Control (NIBSC), part of the MHRA, also plays a major role in assuring the quality of biological medicines, worldwide.
The MHRA Inspectorate blog has several posts covering the approach taken on clinical trials and advice on other areas like remote working.
You can access the full news article and MHRA’s collection here. The collection includes ventilator specifications for companies who are able to manufacture these.
